
Painreform Ltd.
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.
Stock Performance (90 Days)
Layoff History
Recent News
Other Drug Manufacturers - Specialty & Generic Companies
View All →Frequently Asked Questions
Has PAINREFORM LTD. had layoffs?
How many employees does PAINREFORM LTD. have?
What industry is PAINREFORM LTD. in?
Is PAINREFORM LTD. a publicly traded company?
Where is PAINREFORM LTD. headquartered?
Disclaimer
Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.
This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.
Found an error? Report it here.